Physician profile
James Kalpaxis
NPI 1063594281
$3,050.82
in general payments reported to CMS, 2019-2025
17 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $75.45 · 2021: $405 · 2022: $858 · 2023: $378 · 2024: $354 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $390.91 | 2020-2023 | Tecnis Simplicity |
| Glaukos Corporation | $330.50 | 2024-2025 | Idosetr |
| Regeneron Pharmaceuticals, INC. | $284.95 | 2022-2023 | Eylea Hd |
| Bausch & Lomb Americas INC. | $232.63 | 2022-2025 | Envista Mx60 Iol |
| Biotissue Holdings INC. | $229.24 | 2019-2022 | |
| Abbvie INC. | $216.41 | 2019-2022 | |
| Heidelberg Engineering, INC. | $184.27 | 2021 | |
| Carl Zeiss Meditec, INC. | $178.13 | 2019 | |
| Rxsight INC | $150.55 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Alcon Vision LLC | $143.19 | 2025 | Centurion |
| Genentech USA, INC. | $141.42 | 2022 | |
| Horizon Therapeutics Plc | $124.40 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $117.82 | 2023 | Eylea Hd |
| Amgen INC. | $107.67 | 2024 | Tepezza |
| Optovue, INC. | $100.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $98.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kalpaxis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.